Harvard Bioscience, Inc. (HBIO)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$6.59
-3.51%
Mkt Cap $21.73M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $23.10M | $23.73M | +2.75% | $0.35 | -$0.01 | -102.86% | — | — |
| Q4 2025 Nov 6, 2025 | $23.10M | $20.59M | -10.86% | $0.01 | -$0.01 | -300.00% | — | — |
| Q3 2025 Aug 11, 2025 | $19.00M | $20.45M | +7.63% | -$0.03 | -$0.01 | +60.00% | — | — |
| Q2 2025 May 12, 2025 | $21.40M | $21.77M | +1.75% | -$0.04 | -$0.01 | +75.00% | — | — |
| Q1 2025 Mar 12, 2025 | $20.95M | $24.56M | +17.21% | $0.05 | $0.06 | +20.00% | — | — |
| Q4 2024 Nov 7, 2024 | $24.15M | $21.97M | -9.03% | -$0.01 | -$0.02 | -173.97% | — | — |
| Q3 2024 Aug 8, 2024 | $26.40M | $23.10M | -12.51% | $0.05 | -$0.03 | -160.00% | — | — |
| Q2 2024 May 7, 2024 | $25.79M | $24.51M | -4.96% | $0.02 | $0.02 | -14.27% | — | — |
| Q1 2024 Mar 7, 2024 | $29.11M | $28.15M | -3.29% | $0.05 | $0.04 | -20.00% | — | — |
| Q4 2023 Nov 7, 2023 | $29.40M | $25.36M | -13.73% | $0.04 | $0.01 | -75.00% | — | — |
| Q3 2023 Aug 8, 2023 | $29.65M | $28.76M | -3.01% | $0.06 | $0.04 | -33.33% | — | — |
| Q2 2023 Apr 25, 2023 | $29.65M | $29.98M | +1.10% | $0.05 | $0.06 | +20.00% | — | — |
| Q1 2023 Mar 9, 2023 | $30.33M | $28.43M | -6.27% | $0.03 | $0.04 | +20.01% | — | — |
| Q4 2022 Nov 8, 2022 | $28.87M | $26.92M | -6.74% | $0.07 | -$0.01 | -115.00% | — | — |
| Q3 2022 Aug 3, 2022 | $30.49M | $29.21M | -4.19% | $0.06 | $0.05 | -16.67% | — | — |
| Q2 2022 May 4, 2022 | $28.77M | $28.78M | +0.03% | $0.05 | $0.04 | -25.00% | — | — |
| Q1 2022 Mar 8, 2022 | $32.96M | $33.05M | +0.28% | $0.10 | $0.08 | -20.00% | — | — |
| Q4 2021 Nov 3, 2021 | $27.91M | $29.66M | +6.28% | $0.06 | $0.06 | +0.00% | — | — |
| Q3 2021 Aug 5, 2021 | $28.14M | $29.20M | +3.76% | $0.05 | $0.06 | +20.00% | — | — |
| Q2 2021 May 6, 2021 | $22.27M | $26.99M | +21.21% | $0.03 | $0.05 | +50.02% | — | — |